Cerebral Visual Impairment (CVI): A Comprehensive Overview
Vision Development & Rehabilitation · 29.06.2026 · 81
DOI: 10.31707/vdr2026.12.2.p81 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vision Development & Rehabilitation, online erschienen am 29.06.2026. Verfasst von Tamara Petrosyan.
Abstract (Originalsprache)
Cerebral Visual Impairment (CVI), a leading cause of pediatric visual impairment in developed nations, arises from brain-based visual processing deficits rather than ocular abnormalities, affecting over 180,000 US children. With rising prevalence due to improved neonatal care, CVI is frequently associated with neurodevelopmental disorders like cerebral palsy (47-83%), epilepsy (50-53%), and intellectual disability (up to 40%). It presents with diverse symptoms, including fluctuating acuity (20/200 to 20/30), visual field defects, simultanagnosia, dyskinetopsia, and prosopagnosia, often exacerbated by fatigue or seizures. Major etiologies include hypoxic-ischemic encephalopathy (22-35%), seizures (12-31%), cerebral vascular accidents (14%), meningitis (12%), hydrocephalus (10%), and genetic disorders. Pathophysiologically, CVI involves damage to retrochiasmatic pathways, optic radiations, and visual cortex, disrupting dorsal (“where/how”) and ventral (“what”) streams, with periventricular leukomalacia prevalent in preterm infants. Neuroplasticity offers recovery potential, particularly in children, with 20-50% showing functional improvement through early intervention, though 90% remain visually handicapped. Diagnosis requires a multidisciplinary approach, integrating structured history (e.g., Flemish CVI Questionnaire), comprehensive ocular exams (assessing acuity, strabismus [19-38%], nystagmus [11-33%]), neuropsychological testing (e.g., TVPS-3), electrophysiological tests (e.g., VEP), and neuroimaging (e.g., MRI, DTI). Treatment emphasizes habilitation via vision therapy (50+ sessions over 6-12 months), optical corrections (e.g., spectacles, yoked prisms), environmental adaptations (e.g., high-contrast spaces, large fonts), and phase-wise stimulation (light g shapes g colors). Emerging therapies like AI-driven apps, TMS, and stem cell trials show promise.
Zitieren
APA
Petrosyan, T. (2026). Cerebral Visual Impairment (CVI): A Comprehensive Overview. Vision Development & Rehabilitation, 81. https://doi.org/10.31707/vdr2026.12.2.p81
Vancouver
Petrosyan T. Cerebral Visual Impairment (CVI): A Comprehensive Overview. Vision Development & Rehabilitation. 2026:81. doi:10.31707/vdr2026.12.2.p81
BibTeX
@article{Petrosyan2026,
author = {Petrosyan, Tamara},
title = {Cerebral Visual Impairment (CVI): A Comprehensive Overview},
journal = {Vision Development & Rehabilitation},
year = {2026},
pages = {81},
doi = {10.31707/vdr2026.12.2.p81}
}
EUVIMED